Latest Breaking News On - Foundation for embryonic competence - Page 1 : comparemela.com

Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress May 13, 2021 16:01 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES 179% year-over-year revenue increase driven by record sales of consumables and growth in the Saphyr installed base All 2021 milestones on track Strong balance sheet with $362 million cash as of March 31, 2021 Conference call today, Thursday, May 13, at 4:30 pm ET SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the first quarter ended March 31, 2021 and highlighted recent corporate updates. “2021 is off to a solid start for Bionano. In the first quarter, we sold a record number of flow cells, analyzed a record number of samples in our service lab, drove broad adoption of Saphyr instruments and ramped up the installation of Sa

United kingdomSouth africaSouth koreaCity ofErik holmlinLos angelesBionano saphyrAmy conradChris stewartGordana racaUniversity health networkKing college hospitalCompany contactBionano genomics incMd anderson cancer centerRegional genetics laboratory in belfast city hospital